DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
妊娠和新生儿健康研究数据协调中心 (SPAN)
基本信息
- 批准号:10021081
- 负责人:
- 金额:$ 143.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-17 至 2024-07-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAnthropometryCharacteristicsClinical TrialsClinical Trials Data Monitoring CommitteesClinical Trials DatabaseDataData AnalysesData CollectionData Coordinating CenterData SetDatabase Management SystemsDevelopmentDocumentationEnrollmentEpigenetic ProcessFacebookFetal GrowthGeneticGestational DiabetesHealthLongterm Follow-upMonitorNational Institute of Child Health and Human DevelopmentNeonatalNeonatal MortalityNewsletterOnline SystemsPregnancyPreparationRandomizedResearchSchemeSeminal fluidServicesSiteStatistical Data InterpretationSystemTraining ActivityVisitWomancardiovascular risk factorclinical research sitecohortcomputerized data processingdata managementdata quality/integrityearly pregnancyneonatal morbiditypopulation healthprospectiverecruitsocial mediatrial designweb site
项目摘要
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), Division of lntramural Population Health Research (DIPHR) requires data coordinating services for the Study of Pregnancy And Neonatal health (SPAN). SPAN is a prospective pregnancy cohort recruiting women in early pregnancy and retaining them throughout pregnancy with potential for long-term follow-up. The Study has three specific aims -
1) Paternal Contribution to DOHaD (DAD aim): Determine paternal cardiovascular risk and semen epigenetic factors associated with fetal growth, neonatal anthropometry, and placental characteristics;
2) Genetics of fetal Growth And Placental aging (gGAP aim): Identify genetic mechanisms underlying fetal growth, neonatal anthropometry, and placental epigenetic aging; and
3) Timing of delivery for GDM (Gestational Diabetes Mellitus) (TIME aim): Perform a clinical trial using an adaptive trial design to determine the optimal timing of delivery for gestational diabetes complicated pregnancies between 38-39 weeks relative to neonatal morbidity and mortality.
This initiative is for the data coordinating services that will ultimately provide the final dataset and statistical analyses of the data that will be collected from the SPAN Study. This study involves multiple study sites that are responsible for recruitment and enrollment. The data coordinating center (DCC) (this task order) is responsible for organizing a data safety and monitoring board (DSMB) for the trial component. The web-based data collection system will be established by the NICHD's Clinical Trial Database (CTDB, https://ctdb.nichd.nih.gov/ctdb/).
SCOPE
To provide data coordinating services for "the Study of Pregnancy And Neonatal Health." The purpose of this task order is to procure the services of a DCC for preparation, training activities, enrollment and data collection and data analysis of the SPAN study. The DCC shall aid in implementing a web-based data management system from the NICHD CTDB. Major responsibilities include coordination and management of data collection, assuring data quality and integrity, producing thorough data documentation, cleaning and verifying the data,
processing, tracking (study visits, data entry and biospecimens), supporting administrative and regulatory requirements and statistical analyses. In addition, the DCC is responsible for reviewing the study website and working closely with the clinical sites to monitor and oversee the study. The DCC is also responsible for providing a randomization scheme and organizing a DSMB for the clinical trial component of the study and providing a plan for the interim analysis of trial findings. Moreover, the DCC will have the responsibility of providing graphic expertise for newsletter development, study website, and social media (e.g. Facebook posts), as needed.
尤尼斯·肯尼迪·施赖弗国家儿童健康和人类发展研究所 (NICHD) 校内人口健康研究部 (DIPHR) 需要为妊娠和新生儿健康研究 (SPAN) 提供数据协调服务。 SPAN 是一个前瞻性妊娠队列,招募怀孕早期的女性,并在整个怀孕期间保留她们,并有可能进行长期随访。该研究有三个具体目标 -
1) 父亲对 DOHaD 的贡献(DAD 目标):确定父亲心血管风险以及与胎儿生长、新生儿人体测量和胎盘特征相关的精液表观遗传因素;
2)胎儿生长和胎盘衰老的遗传学(gGAP目标):识别胎儿生长、新生儿人体测量和胎盘表观遗传衰老的遗传机制;和
3) GDM(妊娠糖尿病)的分娩时机(TIME 目标):使用适应性试验设计进行临床试验,以确定妊娠期糖尿病并发妊娠 38-39 周相对于新生儿发病率和死亡率的最佳分娩时机。
该举措旨在提供数据协调服务,最终提供最终数据集以及对从 SPAN 研究中收集的数据进行统计分析。这项研究涉及多个负责招募和入组的研究中心。数据协调中心(DCC)(本任务订单)负责为试验组件组织数据安全和监控委员会(DSMB)。基于网络的数据收集系统将由 NICHD 的临床试验数据库(CTDB,https://ctdb.nichd.nih.gov/ctdb/)建立。
范围
为“妊娠与新生儿健康研究”提供数据协调服务。该任务订单的目的是采购 DCC 的服务,以进行 SPAN 研究的准备、培训活动、注册以及数据收集和数据分析。 DCC 应协助实施 NICHD CTDB 的基于网络的数据管理系统。主要职责包括协调和管理数据收集、确保数据质量和完整性、生成完整的数据文档、清理和验证数据、
处理、跟踪(研究访问、数据输入和生物样本)、支持行政和监管要求以及统计分析。此外,DCC 还负责审查研究网站并与临床中心密切合作以监测和监督研究。 DCC 还负责提供随机方案并为研究的临床试验部分组织 DSMB,并为试验结果的中期分析提供计划。此外,DCC 将负责根据需要为时事通讯开发、研究网站和社交媒体(例如 Facebook 帖子)提供图形专业知识。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DANIEL MOLINA其他文献
DANIEL MOLINA的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DANIEL MOLINA', 18)}}的其他基金
PHASE I COCAINE DRUG INTERACTION STUDY. TO6. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 08/10/2023 - 02/09/2025. NIDA REF. NO. N01DA-19-8947.
第一阶段可卡因药物相互作用研究。
- 批准号:
10937276 - 财政年份:2023
- 资助金额:
$ 143.85万 - 项目类别:
FY23. TO5. NIDA PHARMACOKINETIC ANALYSIS RESOURCE CENTER. 01/18/2022 - 04/16/2024. NIDA REF. NO. N01DA-19-8947.
23 财年。
- 批准号:
10948307 - 财政年份:2022
- 资助金额:
$ 143.85万 - 项目类别:
NIAID CLINICAL DATA AND SAFETY MANAGEMENT CENTER (CDSMC)
NIAID 临床数据和安全管理中心 (CDSMC)
- 批准号:
10493771 - 财政年份:2021
- 资助金额:
$ 143.85万 - 项目类别:
DATA COORDINATING CENTER FOR SPROUTS AGES 6- AND 7- YEARS ASSESSMENTS AND STUDY CLOSEOUT
6 岁和 7 岁豆芽数据协调中心评估和研究结束
- 批准号:
10271537 - 财政年份:2020
- 资助金额:
$ 143.85万 - 项目类别:
THE PURPOSE OF THE TO REQUIREMENT IS TO CONDUCT A PHASE I STUDY OF CBD-MORPHINE DRUG-DRUG INTERACTION. TRI HAS CLEARLY DEFINED THE OBJECTIVES OF THE TO IN THEIR PROPOSAL SUBMISSION.
该要求的目的是进行 CBD-吗啡药物相互作用的第一阶段研究。
- 批准号:
10044332 - 财政年份:2019
- 资助金额:
$ 143.85万 - 项目类别:
THE PURPOSE OF THIS REQUIREMENT IS TO PROVIDE OTHER SUPPORT SERVICES TO NIDA AS PART OF CONTRACT PERFORMANCE. SPECIFICALLY, THIS TO INVOLVES WORK DESCRIBED IN TASK G. THE SCOPE OF THIS TASK IS FOR SEV
此要求的目的是作为合同履行的一部分向 NIDA 提供其他支持服务。
- 批准号:
10044188 - 财政年份:2019
- 资助金额:
$ 143.85万 - 项目类别:
DATA COORDINATING CENTER FOR SPROUTS AGE 4 ASSESSMENTS
4 岁豆芽评估数据协调中心
- 批准号:
10025879 - 财政年份:2019
- 资助金额:
$ 143.85万 - 项目类别:
DATA COORDINATING CENTER FOR THE STUDY OF PREGNANCY AND NEONATAL HEALTH (SPAN)
妊娠和新生儿健康研究数据协调中心 (SPAN)
- 批准号:
10271386 - 财政年份:2019
- 资助金额:
$ 143.85万 - 项目类别:
IGF::OT::IGF Task Order 4 for Clinical Support for a phase 1 clinical interaction study between lorcaserin and cocaine POP: 08/18/2014 -08/17/2015.
IGF::OT::IGF 任务令 4,为氯卡色林和可卡因之间的 1 期临床相互作用研究提供临床支持 POP:08/18/2014 -08/17/2015。
- 批准号:
9430254 - 财政年份:2014
- 资助金额:
$ 143.85万 - 项目类别:
CANCER PREVENTION CLINICAL TRIALS AUDITING & INFORMATICS SUPPORT
癌症预防临床试验审核
- 批准号:
9262815 - 财政年份:2014
- 资助金额:
$ 143.85万 - 项目类别:
相似国自然基金
基于可穿戴传感网络的全膝关节置换术后的步态训练研究
- 批准号:51875347
- 批准年份:2018
- 资助金额:60.0 万元
- 项目类别:面上项目
特发性脊柱侧凸生长速率高峰相关纵向人体测量学及遗传学研究
- 批准号:81301603
- 批准年份:2013
- 资助金额:22.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Optimizing Telehealth-delivery of a Weight Loss Intervention in Older Adults with Multiple Chronic Conditions: A Sequential, Multiple Assignment, Randomized Trial
优化对患有多种慢性病的老年人进行远程医疗的减肥干预:一项序贯、多项分配、随机试验
- 批准号:
10583917 - 财政年份:2023
- 资助金额:
$ 143.85万 - 项目类别:
Expanding the pool of Independent Investigators in Implementation Science in Nigeria throug h HIV research training (EXPAND)
通过艾滋病毒研究培训扩大尼日利亚实施科学领域的独立研究者队伍 (EXPAND)
- 批准号:
10872335 - 财政年份:2022
- 资助金额:
$ 143.85万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7
多民族动脉粥样硬化研究 (MESA) 现场中心 (FC) - 任务领域 B 考试 7
- 批准号:
10470555 - 财政年份:2021
- 资助金额:
$ 143.85万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7
多民族动脉粥样硬化研究 (MESA) 现场中心 (FC) - 任务领域 B 考试 7
- 批准号:
10470557 - 财政年份:2021
- 资助金额:
$ 143.85万 - 项目类别:
MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) FIELD CENTER (FC) - TASK AREA B EXAM 7
多民族动脉粥样硬化研究 (MESA) 现场中心 (FC) - 任务领域 B 考试 7
- 批准号:
10470558 - 财政年份:2021
- 资助金额:
$ 143.85万 - 项目类别: